Provided by Tiger Trade Technology Pte. Ltd.

Tempus AI

59.01
+0.27000.46%
Post-market: 58.92-0.0900-0.15%19:59 EDT
Volume:3.69M
Turnover:218.66M
Market Cap:10.71B
PE:-41.16
High:60.38
Open:59.47
Low:58.48
Close:58.74
52wk High:104.32
52wk Low:40.77
Shares:181.56M
Float Shares:115.00M
Volume Ratio:0.69
T/O Rate:3.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4337
EPS(LYR):-1.4100
ROE:-67.44%
ROA:-8.55%
PB:24.08
PE(LYR):-41.85

Loading ...

Biovica Shifts US Strategy to Prioritize Commercial Channels with Faster Revenue Path

Reuters
·
Jun 30

Tempus AI CFO James William Rogers Sells 11,529 Common Shares for $634,095

Reuters
·
Jun 30

Movement Alert|Tempus AI Rises 5.42% in Regular Trading, AI Healthcare Sector Strength and Rare Cancer Collaboration Fuel Gains

Market Focus
·
Jun 30

AI Software Shares Rise. Roblox up over 12%; AppLovin up About 5%; Palantir, TEAM up About 4%; DataDog, ServiceNow up over 3%

Tiger Newspress
·
Jun 29

Movement Alert|Tempus AI Rises 5.67% in Regular Trading, Life Sciences Sector Rallies as Recent FDA Approval and AI Platform Launch Catalyze Gains

Market Focus
·
Jun 25

tempus AI Inc Class A call volume above normal and directionally bullish

TIPRANKS
·
Jun 25

Tempus AI Launches Angiosarcoma Research Collaboration with Angiosarcoma Awareness

Reuters
·
Jun 25

Movement Alert|Tempus AI Rises 5.02% in Regular Trading, Trading at $51.31

Market Focus
·
Jun 24

Anthropic’S Mythos Model Uncovers US Intelligence Vulnerabilities Within Hours; Demonstrates Potent Cyber Defense And Offense Capabilities

AI Industry Frontlines
·
Jun 24

Movement Alert|Tempus AI Falls 5.02% in Regular Trading, Trading at $48.24

Market Focus
·
Jun 22

BofA Warns: AI Bubble Flashes Historic Danger Signals

AI Industry Frontlines
·
Jun 22

Can Tempus AI’s (TEM) New ECG-AF Validation Deepen Its Edge in Clinical-Grade Healthcare AI?

Simply Wall St.
·
Jun 21

Movement Alert|Tempus AI Rises 6.11% in Regular Trading, FDA Approval of xT CDx Platform and Technical Rebound Lift Sentiment

Market Focus
·
Jun 15

Tempus AI says multi-center study validates FDA-cleared ECG model predicting 1-year atrial fibrillation risk

Reuters
·
Jun 11

Movement Alert|Tempus AI Intraday Rise 5.07% in Regular Trading, FDA Approval of xT CDx Platform Combined with Oversold Rebound Lifts Sentiment

Market Focus
·
Jun 10

Movement Alert|Tempus AI Falls 5.47% in Regular Trading, Major Shareholder Continued Selling Pressures Market Sentiment

Market Focus
·
Jun 10

Tempus unit Ambry study finds ExomeReveal RNA testing boosts clarity for uncertain exome results

Reuters
·
Jun 09

If AI Healthcare Wins Big These Three Stocks Could Matter

Simply Wall St.
·
Jun 08

Skip the Oura Ring IPO. Buy These 10 Stocks Instead.

InvestorPlace
·
Jun 07

Is Tempus AI’s (TEM) New Oncology Tools Quietly Redefining Its Precision Medicine Moat?

Simply Wall St.
·
Jun 06